MIR9-1HG

Across TCGA pan-cancer cohorts, MIR9-1HG RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of MIR9-1HG’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where MIR9-1HG RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR9-1HG is over-expressed in tumor, although a few such as BRCA and COAD show the opposite, repressed pattern.

LUAD, KIRC, and LIHC are the cancer types where MIR9-1HG tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR9-1HG RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	All	+0.675	<.001	8	view →
KIRC	Male	All	+0.028	<.001	6	view →
LIHC	All	All	+0.234	.001	5	view →
BRCA	Female	All	−0.182	<.001	4	view →
LUSC	Male	All	+0.323	<.001	3	view →
CHOL	All	All	+0.095	.008	2	view →
ESCA	All	II,III,IV	+0.070	.019	2	view →
COAD	Female	II,III,IV	−0.022	.041	1	view →
KIRP	Female	All	+0.017	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

MIR9-1HG–LUAD

Open the LUAD breakdown →